Kamal Hamed

Kamal Hamed

Geen lopende functies
65 jaar
Health Technology
Consumer Services

Profiel

Kamal Hamed currently works at Spero Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Hamed also formerly worked at Novartis, Inc., as Head-Therapeutic Area from 2005 to 2017, Basilea Pharmaceutica AG, as Head-Clinical Development & Medical Affairs from 2017 to 2022, and Lysovant Sciences, Inc., as Chief Medical Officer in 2022.
Dr. Hamed received his graduate degree from The Johns Hopkins University, Masters Business Admin degree from the University of South Florida, and doctorate degree from American University of Beirut.

Eerdere bekende functies van Kamal Hamed

BedrijvenFunctieEinde
SPERO THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O 01-08-2024
Lysovant Sciences, Inc.
Hoofd Techniek/Wetenschap/O&O 01-08-2022
BASILEA PHARMACEUTICA AG Hoofd Techniek/Wetenschap/O&O 01-02-2022
Corporate Officer/Principal 01-03-2017
Ervaring van Kamal Hamed in detail bekijken

Opleiding van Kamal Hamed

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

9

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Lysovant Sciences, Inc.

  1. Beurs
  2. Insiders
  3. Kamal Hamed